<DOC>
	<DOCNO>NCT01615965</DOCNO>
	<brief_summary>The purpose study set model detect micrometastases Lymph node patient prostate cancer quantitative polymerase chain reaction impact progression-free survival .</brief_summary>
	<brief_title>Detection Micrometastases Lymph Nodes Patients With Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Neoplasm Micrometastasis</mesh_term>
	<criteria>Histologically confirm prostate cancer Locally operable tumor Negative bone scan ( obligatory Gleason Score &gt; 7 PSA &gt; 20ng/ml Karnofsky â‰¥ 80 % Age 18 75 year Informed consent write form Sufficient hematologic , coagulatory renal function Compliant patient geographic precondition adequate followup give Manifest secondary tumor Organ metastases CTscan /MRI Histology Myocardial infarction stroke within last 6 month Severe cardiovascular ( Grade III IV accord NYHA ) , pulmonary ( pO2 &lt; 60 mmHg ) , renal , hepatic oder hematopoetic impairment Severe active chronic infection ( z.B . po . HIVAntibodyTest , HBsAgdetected Serum and/ chronic Hepatitis ) Severe psychiatric disease Previous chemotherapy Previous pelvine radiotherapy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>lymph node</keyword>
	<keyword>micrometastasis</keyword>
</DOC>